Chairman Assistant Yin Bingkui of SEP Analytical (301228.SZ) plans to increase his holdings of the company's shares by 8 to 12 million yuan.
Simpure Detection (301228.SZ) announced that Mr. Yin Bingkui, the special assistant to the chairman of the company, plans to increase his shareholding by using his own funds or self-raised funds through the Shenzhen Stock Exchange system within 6 months from the date of the announcement. He has confidence in the long-term investment value and future development prospects of the company, and plans to increase his shareholding by no less than 8 million yuan and no more than 12 million yuan through centralized bidding or block trading.
SEP Analytical (301228.SZ) announced that Mr. Yin Bingkui, the special assistant to the company's chairman, plans to increase his holdings of the company's shares within 6 months from the date of the announcement. This decision is based on his recognition of the long-term investment value of the company, confidence in the company's future development prospects, and his reasonable and independent judgment of the company's stock value. He plans to use his own funds or self-raised funds to increase his stake in the company through the Shenzhen Stock Exchange system, using either centralized bidding or block trading methods, with the intended increase amount not less than 8 million yuan and not exceeding 12 million yuan.
Related Articles

CONSUN PHARMA (01681) spent 2.6422 million Hong Kong dollars on repurchasing 178,000 shares on December 17th.

MetaSpaceX (01796) signs strategic cooperation memorandum with Guangzhou Xinglun

Shenzhen Kangtai Biological Products (300601.SZ): Recombinant Hepatitis B Vaccine (Brewer's Yeast) (60g) added a new clinical trial approval for the new target population project.
CONSUN PHARMA (01681) spent 2.6422 million Hong Kong dollars on repurchasing 178,000 shares on December 17th.

MetaSpaceX (01796) signs strategic cooperation memorandum with Guangzhou Xinglun

Shenzhen Kangtai Biological Products (300601.SZ): Recombinant Hepatitis B Vaccine (Brewer's Yeast) (60g) added a new clinical trial approval for the new target population project.

RECOMMEND

Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
16/12/2025

What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
16/12/2025

Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
16/12/2025


